MedTrace Logo

Optina Eye to Heart Connection

NCT05199428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 308

Last updated 2024-05-23

No results posted yet for this study

Summary

This is a prospective cross-sectional, single-center retinal imaging study expecting to enroll approximately 400 male and female subjects ≥ 18 years of age. Subjects having undergone clinically-indicated coronary angiography or coronary computed tomography angiography (CCTA) within one month of consent at the Montreal Heart Institute (MHI) will be screened for inclusion in the study.

Conditions

Sponsors & Collaborators

  • Montreal Heart Institute

    collaborator OTHER

  • Optina Diagnostics Inc.

    lead INDUSTRY

Principal Investigators

  • Jean-Claude Tardiff · Montreal Heart Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2024-03-22
Completion
2024-03-22

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05199428 on ClinicalTrials.gov